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Abstract
The aim of the study was to investigate if the interaction between the coagulation factor 2 receptor (F2R) and the
interleukin 6 (IL6) haplotypes modulates the risk of myocardial infarction (MI) in the Stockholm Heart Epidemiology Program
(SHEEP). Seven SNPs at the F2R locus and three SNPs at the IL6 locus were genotyped. Haplotypes and haplotype pairs
(IL6*F2R) were generated. A logistic regression analysis was performed to analyze the association of the haplotypes and
haplotype pairs with the MI risk. Presence of an interaction between the two haplotypes in each haplotype pair was
calculated using two different methods: the statistical, on a multiplicative scale, which includes the cross product of the two
factors into the logistic regression model; the biological, on an additive scale, which evaluates the relative risk associated
with the joint presence of both factors. The ratio between the observed and the predicted effect of the joint exposure, the
synergy index (S), indicates the presence of a synergy (S.1) or of an antagonism (S,1). None of the haplotypes within the
two loci was associated with the risk of MI. Out of 22 different haplotype pairs, the haplotype pair 17 GGG*ADGTCCT was
associated with an increased risk of MI with an OR (95%CI) of 1.58 (1.05–2.41) (p=0.02) in the crude and an OR of 1.72 (1.11–
2.67) (p=0.01) in the adjusted analysis. We observed the presence of an interaction on a multiplicative scale with an OR
(95%CI) of 2.24 (1.27–3.95) (p=0.005) and a slight interactive effect between the two haplotypes on an additive scale with
an OR (95%CI) of 1.56 (1.02–2.37) (p=0.03) and S of 1.66 (0.89–31). In conclusion, our results support the hypothesis that the
interaction between these two functionally related genes may influence the risk of MI and suggest new mechanisms
involved in the genetic susceptibility to MI.
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Introduction
The study of interactions between genes coding for proteins
involved in common metabolic pathways might shed light on the
complex mechanisms underlying the pathogenesis of complex
diseases.
A large body of evidence indicates that the interplay between
thrombosis and inflammation plays a crucial role in the
progression of atherosclerotic plaque growth and may drive the
plaque towards rupture or stabilization [1]. The thrombin
receptor, the coagulation factor 2 receptor (F2R), is a critical
modulator of inflammation and thrombosis crosstalk in the vessel
wall [2]. Studies performed in vitro have demonstrated that in
endothelial cells thrombin stimulates a plethora of pro-inflamma-
tory mediators thus exerting a pro-atherogenic effect [3,4,5]. In
particular, F2R stimulates the synthesis of interleukin 6 (IL6) a
cytokine exerting strong pro-atherogenic effects that mediate the
transition of the inflammatory process in the vascular wall from an
acute to a chronic phase [6]. Increased levels of serum IL6
represent an established risk factor for coronary heart disease
[7,8].
Recently, we have shown that a promoter (21738 G/A) and an
intronic (2860 G/A) F2R genetic variant and their related
haplotypes are associated with higher IL6 serum levels and
modulate the risk of myocardial infarction (MI) in male patients
through the interaction with IL6 serum levels [9].
The aim of this study was to analyze the presence and the
potential role of an interaction between F2R and IL6 haplotypes
on the risk of MI in a large case control population recruited in the
Stockholm area, the Stockholm Heart Epidemiology Program
(SHEEP).
Results
Pairwise linkage disequilibrium (LD) values between F2R SNPs
in the SHEEP have been already reported [9]; LD values between
SNPs within the IL6 gene are as follows: rs1800795–rs1800796
and rs1800795–rs2069840 r
2=0.051 [7] and 0.03, respectively;
rs1800796–rs2069840 r
2=0.36).
None of the F2R and IL6 haplotypes were associated with the
risk of MI in men in the SHEEP study (Figure 1A and 1 B, bottom
panel).
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | e11300The twenty-two most common haplotype pairs (IL6*F2R) in
men are listed in Table 1. Haplotype pair 17 (GGG*ADGTCCT)
was more frequent in cases (p=0.04), while haplotype pairs 14,15
and 16 were observed more often in controls although the
difference fell short of significance.
We performed a logistic regression analysis to test if these four
haplotype pairs were associated with the risk of MI. As shown in
Table 2, the haplotype pair 14 was associated with a reduction in
the MI risk at the adjusted analysis while the presence of the
haplotype pair 17 was associated with an increased risk of MI with
an OR of 1.58 (1.05–2.41) at the crude and an OR of 1.72 (1.11–
2.67) at the adjusted analysis.
To investigate the mechanisms underlying this observation we
tested the hypothesis of an interaction between IL6 and F2R
haplotypes in the haplotype pair 17 (Table 3) and 14. Under the
assumption of a biological interaction, joint presence of the IL6 and
F2R haplotypes was associated with an OR (95%CI) of 1.56 (1.02–
2.37). The calculation of the S (95%CI) gave a value of 1.66 (0.89–
31). When the interaction between these twohaplotypes was tested on
a multiplicative scale we observed that the cross product of these two
haplotypes was associated with an OR of 2.24 (1.27–3.95) (p=0.004).
No significant interaction between the two haplotypes at haplotype
pair 14 was observed either under a biological [OR 0.77 (0.50–1.17),
p=0.22] or a statistical [OR 0.66 (0.35–1.22), p=0.18] model.
Discussion
Haplotypes may be considered as ‘‘super-alleles’’ where the
different genetic variants encoded act in synergy and contribute to
determine the biological function of a protein, through changes in
its primary, secondary or tertiary structure [10]. In this perspective
haplotypes may have a greater power to detect the association of
candidate genes with a complex phenotype by either capturing the
effect of un-genotyped causal SNPs or, in the presence of several
SNPs each one exerting a small effect hardly detected when the
single variants are analyzed separately, by identifying new
candidate genes and/or genetic variants [11,12].
Studies performed so far in vitro on the adrenergic receptors
have suggested that different haplotypes might regulate selective
biological pathways and physiological responses to different stimuli
[12]. More recently we have also shown that selective F2R
haplotypes are associated with peculiar phenotypes [9,13]. In the
present study we sought to investigate if IL6 and F2R haplotype
pairs were associated with the risk of MI. This hypothesis was
driven by our former study showing that two F2R SNPs modulate
IL6 serum levels and interact with IL6 serum levels in determining
the risk of MI [9], suggesting the presence of an interaction
between IL6 and F2R genes. The modifying effect on the risk of a
disease exerted by the concomitant presence of two haplotypes,
encoding the same gene or two genes involved in the same
metabolic pathway has been already reported, among others, in a
study of the Islandic population where the selective haplotype
combinations within the gene encoding phosphodiesterase 4D
were found to confer a differential risk of stroke [14] and in the
German MI family study where haplotypes within the ghrelin gene
were associated with a reduced risk of MI only in the presence of
selective haplotypes encoding the ghrelin receptor, thus suggesting
the presence of an epistatic interaction between these two genes
Figure 1. F2R and IL6 genes: tag SNPs and haplotype frequencies. Top panel. Schematic representation of F2R (Panel A) and IL6 (Panel B)
tagSNPs mapping position. Ex: exon, 39UTR: 39untranslated region. Bottom panel. Table illustrating F2R (Panel A) and IL6 (Panel B) haplotype
frequency in SHEEP male cases and controls. The table reported in panel A has been modified from Gigante B. et al, Thromb Haemost.
2009;101(5):943–953 (permission to reprint obtained from the publisher).
doi:10.1371/journal.pone.0011300.g001
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the analysis of the association of haplotypes coding different genes
may disclose the presence of a genetic effect that it is not readily
observed when analyzing each gene separately. Given the
complexity of the mechanisms through which genes affect the
occurrence of complex traits, it has been hypothesized that the
presence of one or more haplotypes in different genes involved in
the same metabolic pathways of importance for the progression of
a disease may influence the genetic load of an individual thus
increasing or decreasing the individual susceptibility to suffer from
complex disorders [16].
Different approaches have been undertaken to analyze the
observed interaction effect [15,16] between haplotypes or to
investigate the presence of potential haplotypes interactions to
partly explain the genetic variance in complex traits [17]. We tested
our hypothesis under two different interaction models, a biological
model that measureson an additivescale the risk differencebetween
different exposures, and a statistical model on a multiplicative scale
that considers the difference in the relative risk of a disease in the
presence of both factors [18]. In the biological model we observed a
borderline additive interaction effect on the risk of MI in individuals
carrying the haplotype pair 17 as shown by the wide confidence
interval relativeto the S index;inthe statisticalinteraction modelwe
did observe a significant interaction between the two haplotypes.
The results obtained by these two models are not readily
comparable since they evaluate two different aspects of the
interaction between two factors [19]. Presence of a multiplicative
and absence of an additive interaction among two correlated genes
has been already described [20] and probably reflects the
complexity of the interaction between two genes in multifactorial
diseases. The presence of an interaction on a multiplicative scale
may reflect the role of other genes and/or environmental factors
that participate in the same metabolic pathway and are therefore
indirectly involved in determining the observed interactive effect.
Several limitations of the present study need to be acknowl-
edged. The number of individuals in the rarest haplotypes is rather
small and this may result in the loss of power in the interaction
analysis; the replication of haplotype association studies is limited
by the diversity of the haplotype structure of the same gene among
different populations [9,21] and finally in vitro or ex vivo studies
are needed to obtain the biological proof of different effects related
to different haplotypes within the same gene.
In conclusion, our results support the hypothesis that a genetic
interaction between the thrombin receptor and the interleukin 6
gene plays a role in the occurrence of myocardial infarction. In a
broader perspective, our results suggest new mechanisms to be
further explored in the analysis of the association of genes with
complex traits.
Methods
Study Population
SHEEP was designed as a population based case-control study
to dissect both genetic and environmental factors underlying the
occurrence of MI and to compare the effects of the different risk
factors in men and women [22].
Briefly, SHEEP comprises Swedish citizens living in the
Stockholm County who were 45–70 years of age and free of
Table 1. Absolute frequency of IL6*F2R haplotype pairs in
male cases and controls.
Pair IL6 Hap F2R Hap Cases (%) Controls (%)
1 GCC GDACCCT 227 (10.4) 289 (10.7)
2 GCC GIATACT 236 (10.8) 274 (10.2)
3 GCC ADGTCTC 201 (9.2) 233 (8.7)
4 GGG GDACCCT 151 (6.9) 204 (7.6)
5 GGG GIATACT 153 (7) 183 (6.8)
6 GCC ADGTCTT 131 (6) 153 (5.7)
7 GGG ADGTCTC 132 (6) 153 (5.7)
8 GGC GDACCCT 113 (5.1) 144 (5.4)
9 GGC GIATACT 113 (5.2) 124 (4.6)
10 GGG ADGTCTT 93 (4.2) 118 (4.3)
11 GGC ADGTCTC 88 (4) 115 (4.3)
12 GCC ADGTCCT 81 (3.7) 99 (3.7)
13 GCC ADGTCCC 79 (3.6) 84 (3.1)
14 GCC GDGTCTT 58 (2.6) 91 (3.3)
15 GGC ADGTCTT 52 (2.3) 83 (3)
16 GGG GDGTCTT 33 (1.5) 61 (2.2)
17 GGG ADGTCCT 62 (2.9) 55 (2)
18 GGG ADGTCCC 54 (2.4) 56 (2)
19 GGC ADGTCCT 31 (1.4) 53 (1.9)
20 GCC ADGTACT 25 (1.1) 42 (1.5)
21 GGC ADGTCCC 37 (1.7) 39 (1.4)
22 GCC GDACCTC 29 (1.3) 31 (1.1)
doi:10.1371/journal.pone.0011300.t001
Table 2. Estimated effect of haplotype pairs 14, 15, 16 and 17
on the risk of MI.
Crude* Adjusted**
OR (95%CI) P OR (95%CI) P
Pair 14 (GCC*GDGTCTT) 0.77 (0.55–1.09) 0.14 0.69 (0.48–0.99) 0.04
Pair 15 (GGC*ADGTCTT) 0.79 (0.55–1.14) 0.20 0.80 (0.55–1.17) 0.25
Pair 16 (GGG*GDGTCTT) 0.66 (0.42–1.02) 0.06 0.62 (0.37–1.04) 0.07
Pair 17 (GGG*ADGTCCT) 1.58 (1.05–2.41) 0.02 1.72 (1.11–2.67) 0.01
*Adjusted for age and hospital catchment area.
**Adjusted for age, hospital catchment area, hypertension, diabetes, smoking,
body mass index .30 and hypercholesterolaemia.
doi:10.1371/journal.pone.0011300.t002
Table 3. Interaction between the IL6 Hap2 and F2R Hap6 on
a multiplicative and on an additive scale.
N OR (95%CI) P
IL6HapGGG 633 0.91 (0.74–1.12) 0.38
F2R HapADGTCCT 123 0.75 (0.51–1.10) 0.15
Multiplicative
IL6XF2R (Pair 17) 98 2.24 (1.27–3.95) 0.005
Additive
IL6+F2R (Pair 17) 98 1.56 (1.02–2.37) 0.03
All individuals homozygotes for IL6 HapGGG (n=18) or for F2R HapADGTCCT
(n=1) have been excluded from the interaction analysis.
doi:10.1371/journal.pone.0011300.t003
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and only patients who survived at least 28 days after the MI event
were included in the present study (n=1213). One control per
case was randomly selected from the Stockholm County
population registry after stratification for age (with a 5-years
interval), sex and hospital catchment area. In addition other 5
controls were selected at the same time to replace eventual non-
responders. When the initial control replied late, both the initial
and the already enrolled substitute control have been included in
the study. This resulted in the inclusion of more controls (n=1561)
than cases. A more detailed description of the SHEEP population
has been reported elsewhere [9,22] The study was approved by the
Ethics Committee at the Karolinska Institutet (Stockholm,
Sweden).
Ethics
The Ethical Committee at Karolinska Institutet approved the
SHEEP study design in 1991 (Protocol Number 1991, 91:259). All
the study participants gave their informed oral consent to be
enrolled in the study, since at the time the study was initiated
(1992) no forms for the written consent were available or in
current use. The Ethical Committee at Karolinska Institutet has
then approved molecular genetic analyses to be performed on the
SHEEP material in 2001 (Protocol Number 2001, 01-097).
Tag Single Nucleotide Polymorphisms (tSNPs) selection
and genotyping and haplotypes generation
The following 7 tSNPs mapping within F2R gene were selected
through HapMap (www.hapmap.org) and genotyped as previously
described [9,13]: 21738 G/A (rs2227744), 2506D/I (rs11267092)
in the promoter, 2860 G/A (rs27135), 2930 C/T (rs27593) and
9113 C/A (rs2227774), 9333C/T (rs37250) in the intron, and
1801719T/C (rs1801719 ) in the 39untranslated region (Figure 1A,
top panel) . Three tSNPs were selected through HapMap for the
IL6 gene 2573 G/C (rs1800795) and 2174G/C (rs1800796) in
the promoter were genotyped as previously described [7], and
3437C/G (rs2069840) in the 3
rd intron (Figure 1B, top panel) was
genotyped by Taqman with a custom made assay purchased from
Applied Biosystems (ABI).
Haplotypes were generated from the original genotype data
using the software PHASE v2 [23].
Statistical Analysis
Based on our former results showing that the effects of F2R on
MI risk is absent among women [9], the present study was
restricted to an all male population. For each SNP, concordance to
the Hardy-Weinberg equilibrium was tested by x2 test with 1DF.
The pairwise LD values between the SNPs were assessed by
THESIAS [24].
We tested the association of the F2R and the IL6 haplotypes,
generated from the original genotype data, with myocardial
infarction by THESIAS [24]. The algorithm used in THESIAS
takes the most commonly observed haplotype in the population
under investigation as the reference category and expresses the risk
associated with the presence of each one of the other haplotypes as
odds ratios (ORs) with 95% confidence intervals (CI) [(ORs (95%
CI)]. For the purpose of our analysis crude OR (95%CI) were
adjusted for the study design variables age and hospital catchment
area.
We have then calculated the absolute frequency of each
haplotype pair (IL6* F2R) taking into account all the possible
haplotype pairs for each individual. The following inclusion/
exclusion criteria were followed: haplotypes with more than 3
dropouts for F2R and IL6 genotypes were excluded, only
individuals with complete haplotype information for both genes
were included and only haplotype pairs with a frequency $1%
have been included in the analysis. The analysis was then
performed on 1728 individuals. To correct for the analysis of
multiple SNPs within a gene we have used a gene-wide
significance level (P) that takes into account the overall genetic
variation in the genes under investigation [25]. The actual p value
is corrected according to the ratio (r) SNPs tested/all SNPs
validated within a gene applying the formula P=12(120.05)
r.
According to the most recent version of HapMap (Feb09) 17 SNPs
have been validated within the F2R gene and 10 in the IL6 gene.
Of these 5/17 and 5/10 were found to be in high LD (r
2.0.95)
and therefore not included in the present analysis giving a
threshold p value of 0.03 for both genes.
The difference in the frequency of IL6 and F2R haplotypes pair
(IL6* F2R) between cases and controls has been tested by x
2 test
with 1DF. The association of the each haplotype pair with MI has
been performed through a logistic regression analysis and the
results expressed as odds ratio (OR) and 95% confidence interval
(95%CI). The crude OR (95%CI) were adjusted for the study
design variables (indicated as crude) and further adjusted for
hypertension (defined as blood pressure values.140/90 mmHg or
use of an anti-hypertensive medication), diabetes (blood glucose
levels.6.7 mmol/L or diabetes controlled with diet, oral drug
treatment or insulin), smoking (current smoking within the last two
years), body mass index .30 and hypercholesterolemia (serum
level of total cholesterol $6.46 mmol/L or treatment with lipid
lowering drugs) in the multivariate analysis (indicated as adjusted).
We have then explored the presence of an interaction effect
between the haplotypes within haplotype pairs associated with MI
using two different methods: a biological, on an additive scale, and
a statistical, on a multiplicative scale. To estimate the presence of a
biological interaction between the two haplotypes in a specific
haplotype pair, we have estimated by logistic regression analysis
the risk, expressed as OR (95%CI), associated with the presence of
one haplotype in the absence of the other one (i.e. IL6 GGG but
not F2R ADGTCCT [AO] and F2R ADGTCCT but not IL6
GGG [OB]) and the risk associated with the presence of both
haplotypes (i.e. GGG+ADGTCCT [AB]) taking as reference
group all the individuals not exposed to either or both haplotypes
[OO]. The presence of synergism or antagonism between two
factors is expressed by the synergy index (S) 95% CI. The presence
of a S value higher than 1 indicates the presence of a synergism
between the two haplotypes, the presence of a S value lower than 1
indicates the presence of an antagonism between the two
haplotypes [26]. The formula to calculate S has been reported
by Rothman [27] and derives from the ratio between the risk (R)
observed in the presence of both haplotypes minus the risk
observed in the reference group and the risk predicted by the sum
of the risk observed in individuals exposed to only one factor
minus twice the risk in the reference group (i.e. RAB-ROO/
RAO+ROB-2XROO).
To estimate the presence of a statistical interaction the cross
product of the two factors was included as a variable in the logistic
regression model.
Calculations were carried out using SAS (vers 9.1, SAS Institute
Inc. Cary, NC).
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